Business
Zymfentra (Celltrion) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Opportunities in the Zymfentra market include advancements in enzyme therapies, boosted by regulatory approvals, rising R&D investments, improved homecare models, and a growing focus on rare genetic disorders and aging populations. Challenges include tariffs affecting costs, driving localized production.Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Zymfentra Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. Th
About this update from Celltrion, Inc.
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/g_3H8YP5.WdAX5cBtX03VA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"Opportunities in the Zymfentra market include advancements in enzyme therapies, boosted by regulatory approvals, rising R&D investments, improved homecare models, and a growing focus on rare genetic disorders and aging populations. Challenges include tariffs affecting costs, driving localized production.","length":309,"tagName":"p"},{"type":"text","content":"Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Zymfentra Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.","length":211,"tagName":"p"},{"type":"text","content":"The Zymfentra market is experiencing significant growth, driven by several key factors across both historic and forecast periods. Historically, advancements in recombinant enzyme development and enhanced diagnosis of rare metabolic disorders have played a crucial role. Access to orphan drug incentives, expanded specialty treatment centers, and growing patient access programs have also fueled market growth.","length":409,"tagName":"p"},{"type":"text","content":"Looking ahead, increased investments in rare disease research, a surge in demand for long-term enzyme therapies, and the expansion of homecare treatment models are expected to continue driving growth. The use of digital patient monitoring tools and improved reimbursement frameworks further support market expansion. The forecast period is characterized by trends such as the adoption of personalized treatment approaches, advancements in biologic manufacturing processes, and an increase in home-based infusion therapies.","length":522,"tagName":"p"},{"type":"text","content":"Demographic shifts, particularly the rising aging population, are significant drivers of the Zymfentra market. As the global population aged 60 and above is projected to rise dramati...